CoChat

Perspectives on Hypoxia Signaling in Tumor Stroma

Open access

The DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Hypoxia is a well-known characteristic of solid tumors that contributes to tumor progression and metastasis. Oxygen deprivation due to high demand of proliferating cancer cells and standard of care therapies induce hypoxia. Hypoxia signaling, mainly mediated by the hypoxia-inducible transcription factor (HIF) family, results in tumor cell migration, proliferation, metabolic changes, and resistance to therapy. Additionally, the hypoxic tumor microenvironment impacts multiple cellular and non-cellular compartments in the tumor stroma, including disordered tumor vasculature, homeostasis of ECM. Hypoxia also has a multifaceted and often contradictory influence on immune cell function, which contributes to an immunosuppressive environment. Here, we review the important function of HIF in tumor stromal components and summarize current clinical trials targeting hypoxia. We provide an overview of hypoxia signaling in tumor stroma that might help address some of the challenges associated with hypoxia-targeted therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers13123070

Cites

188 of 189 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Hypoxia affects the tumor stroma. In addition to multiple effects of hypoxia on cancer cells, hypoxia through HIF-1α signaling regulates the tumor stroma, including tumor vasculature, ECM, CAFs, and immune cells. HIF signaling is essential for vessel growth and maturation. Hypoxia also regulates CAF functions and leads to increased secretion of ECM components. However, the effects of hypoxia on each type of immune cell are complex and, in some cases, controversial. In general, hypoxia results in infiltration of immunosuppressive cells such as TAMs and Tregs and regulates the differentiation, phenotype polarization, as well as the cytotoxic function of immune cells to create an immunosuppressive environment. Hypoxia contributes to tumor progression, metastasis, and compromises the efficacy of standard of care therapy and immunotherapy in numbers of indications. Green arrow pointing down, decreased; red arrow pointing up, increased.
Figure 1 Hypoxia affects the tumor stroma. In addition to multiple effects of hypoxia on cancer cells, hypoxia through HIF-1α signaling regulates the tumor stroma, including tumor vasculature, ECM, CAFs, and immune cells. HIF signaling is essential for vessel growth and maturation. Hypoxia also regulates CAF functions and leads to increased secretion of ECM components. However, the effects of hypoxia on each type of immune cell are complex and, in some cases, controversial. In general, hypoxia results in infiltration of immunosuppressive cells such as TAMs and Tregs and regulates the differentiation, phenotype polarization, as well as the cytotoxic function of immune cells to create an immunosuppressive environment. Hypoxia contributes to tumor progression, metastasis, and compromises the efficacy of standard of care therapy and immunotherapy in numbers of indications. Green arrow pointing down, decreased; red arrow pointing up, increased.CC BY · PubMed Central
Figure 2 HIF signaling effects on immune cells in the tumor microenvironment. HIF signaling, mainly HIF-1α generally promotes an immunosuppressive microenvironment. In TAMs and MDSCs, HIF-1α contributes to their infiltration and enhanced suppressive capacity on effector T cells. HIF-1α can also stimulate a proangiogenic phenotype of TAMs and TAM-mediated ECM remodeling. The hypoxic microenvironment stimulates the secretion of cytokines and chemokines from tumor cells or TAMs to recruit Tregs, further limiting effector T cell function. There is conflicting evidence of HIF signaling in determining T cell fate. HIF-1α has been demonstrated to induce or inhibit differentiation of naïve CD4+ T cells into Th17 T cells or Tregs. HIF-1α signaling also exhibits controversial effects on effector T cell function and the migration and maturation of DCs. The effect of hypoxia on DC and T cell interaction is an area ripe for further investigation. Green arrow pointing down, decreased; red arrow pointing up, increased.
Figure 2 HIF signaling effects on immune cells in the tumor microenvironment. HIF signaling, mainly HIF-1α generally promotes an immunosuppressive microenvironment. In TAMs and MDSCs, HIF-1α contributes to their infiltration and enhanced suppressive capacity on effector T cells. HIF-1α can also stimulate a proangiogenic phenotype of TAMs and TAM-mediated ECM remodeling. The hypoxic microenvironment stimulates the secretion of cytokines and chemokines from tumor cells or TAMs to recruit Tregs, further limiting effector T cell function. There is conflicting evidence of HIF signaling in determining T cell fate. HIF-1α has been demonstrated to induce or inhibit differentiation of naïve CD4+ T cells into Th17 T cells or Tregs. HIF-1α signaling also exhibits controversial effects on effector T cell function and the migration and maturation of DCs. The effect of hypoxia on DC and T cell interaction is an area ripe for further investigation. Green arrow pointing down, decreased; red arrow pointing up, increased.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 189 references

Cited by

See all 41

Metadata

Authors
Zhang, Y., Coleman, M., & Brekken, R. A.
Affiliations
The University of Texas Southwestern Medical Center (US)
Corresponding author
Brekken, Rolf A.
Venue
Cancers
Publisher
MDPI AG
Published
2021-06-20
Volume
13
Issue
12
Pages
3070
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3174016551
Cited by
39
References
189
Citations by year
2026: 8 · 2025: 8 · 2024: 5 · 2023: 5 · 2022: 10 · 2021: 3
FWCI
0.69
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health (U54 CA210181 (Project 2); R01 CA243577)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
tumor hypoxia, hypoxia signaling, hypoxia-inducible factor, tumor stroma, tumor microenvironment, tumor vasculature, extracellular matrix, tumor immune microenvironment, immunosuppression, treatment resistance, hypoxia-targeted therapy, tumor progression, metastasis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Perspectives on Hypoxia Signaling in Tumor Stroma. https://app.cochat.ai/papers/10.3390/cancers13123070
The paper
Zhang, Y., Coleman, M., & Brekken, R. A. (2021). Perspectives on Hypoxia Signaling in Tumor Stroma. Cancers. https://doi.org/10.3390/cancers13123070

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.